Gronghui Health released Yingxi forecast on July 15: as of June 30, 2022, according to unaudited operating data, the group's revenue and gross profit margin continued to grow strongly in the first half of the year. Among them, the group's total income for the first half of the year is expected to range from 217.1 million yuan to 231.6 million yuan (RMB, the same below), an increase of 394.5% to 427.6% compared with 43.9 million yuan for the same period in 2021, and gross profit for the first half of the year is expected to range from 182.2 million yuan to 191.1 million yuan, an increase of 637.7% to 673.7% compared with 24.7 million yuan in the same period in 2021. The company's gross profit margin for the first half of the year to June 30, 2022 is expected to range from 78.7% to 88.0%, which continues to increase over the same period last year. For the same period last year, as of June 30, 2021, the gross profit margin was 56.2%. The increase in performance is mainly due to the increase in income and gross profit of Chang Weiqing and Pupu tube, as well as the launch of a new product, claustrophobic, in January 2022.
Specifically, Chang Weiqing's sales revenue for the first half of the year is expected to range from 69.4 million yuan to 76.9 million yuan, an increase of 388.7% to 441.5% compared with the same period last year; and the expected range of gross profit margin for the first half is 72.0% to 87.0%, a sharp increase over the same period last year. Pupu tube's sales revenue for the first half of the year is expected to range from 66.6 million yuan to 70.1 million yuan, an increase of 125.2% to 136.8% over the same period last year; and the expected range of gross profit margin for the first half is 76.6% to 83.3%, a sharp increase over the same period last year. In addition, the sales revenue of Youyou Tube since its launch in January this year is expected to range from 81 million yuan to 84.5 million yuan, and the gross profit margin for the first half of this year is expected to be 87.2% to 93.2%.